Targeting acetylated high mobility group box 1 protein (HMGB1) and toll‐like receptor (TLR4) interaction to alleviate hypertension and neuroinflammation in fructose‐fed rats
Targeting acetylated high mobility group box 1 protein (HMGB1) and toll-like receptor (TLR4) interaction to alleviate hypertension and neuroinflammation in fructose-fed rats
British Journal of Pharmacology · 2026-01 · 183 (1) · 171-188
DOI: 10.1111/bph.17402 ↗Auf einen Blick
Bei fructosegefütterten Ratten senkten CLI-095 und Glycyrrhizinsäure den Blutdruck und verminderten die Neuroinflammation im NTS. Beide Behandlungen verhinderten die Interaktion von acetylierter HMGB1 mit TLR4.
Fragestellung
Welche Wirkung haben CLI-095 und Glycyrrhizinsäure auf Blutdruck, NO-System und Neuroinflammation im NTS bei fructoseinduziertem Bluthochdruck?
Methode
Experimentelle Tierstudie an männlichen Wistar-Kyoto-Ratten mit 10 % Fructosewasser; Behandlung mit CLI-095 oder Glycyrrhizinsäure bis zu 2 Wochen per intrazerebroventrikulärer Injektion.
Ergebnisse
Nach 2 Wochen reduzierten CLI-095 und Glycyrrhizinsäure den systemischen Blutdruck, erhielten nNOS- und eNOS-Verfügbarkeit, senkten NTS-Entzündung und Serum-Noradrenalin und blockierten die Interaktion von acetylierter HMGB1 mit TLR4.
Schlussfolgerung der Autor:innen
Die Daten zeigen neue pharmakologische Eigenschaften von CLI-095 und Glycyrrhizinsäure; beide verbesserten Blutdruck und Entzündungszustand durch Verringerung der Interaktion von acetylierter HMGB1 mit TLR4.
Kernaussagen
- 2 Wochen CLI-095 oder Glycyrrhizinsäure senkten den Blutdruck
- NTS-Entzündung und Serum-Noradrenalin nahmen ab
- HMGB1-TLR4-Interaktion wurde gehemmt
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Pharmacology, online erschienen am 03.12.2024. Verfasst von Yu-Te Lin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Section of Neurology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan. Hauptthemen laut MEDLINE: Toll-Like Receptor 4, HMGB1 Protein, Fructose, Hypertension. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Technology, Taiwan, Kaohsiung Veterans General Hospital.
Themen: Mobilisation
Abstract (Originalsprache)
Background and Purpose Our previous study reported that fructose intake increased systemic blood pressure and reduced nitric oxide (NO) in the nucleus tractus solitarius (NTS) due to oxidative stress and neuroinflammation. However, it remains unclear how reactive oxygen species (ROS) reduce NO and how this process impacts neuroinflammation in the NTS. This study aimed at investigating the effect of ROS on acetylation of high mobility group box 1 protein (HMGB1) in the NTS of fructose‐induced hypertensive rats. Experimental Approach Male Wistar‐Kyoto (WKY) rats were fed with 10% fructose water to elevate blood pressure. Thereafter, CLI‐095 and glycyrrhizic acid (GA) treatments were delivered for up to 2 weeks (1 mg·12 μL −1 ·day −1 , by intracerebroventricular injection) to reduce the negative effects of toll‐like receptor 4 (TLR4) and HMGB1 activation. Key Results Two weeks of CLI‐095 and GA treatment reduced systemic blood pressure and significantly preserved neuronal and endothelial nitric oxide synthase (nNOS and eNOS) availability against the inflammatory insults of fructose consumption. Both CLI‐095 and GA halted the interaction of acetylated HMGB1 and TLR4. Two weeks of CLI‐095 and GA treatment markedly reduced NTS inflammation (pro‐inflammatory cytokines and microglial activation) and lowered serum norepinephrine levels. Conclusion and Implications Our data reveal novel pharmacological properties for CLI‐095 and GA, which improved blood pressure and inflammatory conditions by decreasing the interaction of acetylated HMGB1 with TLR4. These findings challenge the commonly accepted dogma that essential hypertension is specifically mediated by neuroinflammation due to acetylated HMGB1 coupling to TLR4. LINKED ARTICLES This article is part of a themed issue Recent Innovations in Targeting Redox Biology for Therapeutics. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v183.1/issuetoc
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Section of Neurology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.
- Center for Geriatrics and Gerontology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.
- Institute of Biomedical Sciences, National Sun Yat-sen University, Kaohsiung, Taiwan.
- Department of Medical Education and Research, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.
- Department of Anesthesiology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.
- Cross College Elite Program, National Cheng Kung University, Tainan, Taiwan.
ORCID-Profile: Michael Hsiao, Pei-Wen Cheng
Förderung
- Ministry of Science and Technology, Taiwan
- Kaohsiung Veterans General Hospital
Zitieren
APA
Lin, Y. T., Ho, C. Y., Sun, G. C., Wong, T. Y., Hsiao, M., Tseng, C. J., & Cheng, P. W. (2026). Targeting acetylated high mobility group box 1 protein (HMGB1) and toll‐like receptor (TLR4) interaction to alleviate hypertension and neuroinflammation in fructose‐fed rats. British Journal of Pharmacology, 183(1), 171-188. https://doi.org/10.1111/bph.17402
Vancouver
Lin YT, Ho CY, Sun GC, Wong TY, Hsiao M, Tseng CJ, et al. Targeting acetylated high mobility group box 1 protein (HMGB1) and toll‐like receptor (TLR4) interaction to alleviate hypertension and neuroinflammation in fructose‐fed rats. British Journal of Pharmacology. 2026;183(1):171-188. doi:10.1111/bph.17402
BibTeX
@article{Lin2026,
author = {Lin, Yu-Te and Ho, Chiu-Yi and Sun, Gwo-Ching and Wong, Tzyy-Yue and Hsiao, Michael and Tseng, Ching-Jiunn and Cheng, Pei-Wen},
title = {Targeting acetylated high mobility group box 1 protein (HMGB1) and toll‐like receptor (TLR4) interaction to alleviate hypertension and neuroinflammation in fructose‐fed rats},
journal = {British Journal of Pharmacology},
year = {2026},
volume = {183},
number = {1},
pages = {171--188},
doi = {10.1111/bph.17402}
}
EUVIMED